Roger D. Dansey - Aug 16, 2021 Form 4 Insider Report for Seagen Inc. (SGEN)

Role
Chief Medical Officer
Signature
By: /s/ Elizabeth Bekiroglu For: Roger D. Dansey
Stock symbol
SGEN
Transactions as of
Aug 16, 2021
Transactions value $
-$256,096
Form type
4
Date filed
8/18/2021, 08:28 PM
Previous filing
Aug 13, 2021
Next filing
Sep 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Sale -$256K -1.66K -2.23% $154.55 72.8K Aug 16, 2021 Direct F1, F2
transaction SGEN Common Stock Award $0 +17.2K +23.6% $0.00 90K Aug 16, 2021 Direct F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGEN Incentive Stock Option (right to buy) Award $0 +642 $0.00 642 Aug 16, 2021 Common Stock 642 $155.87 Direct F5
transaction SGEN Non-Qualified Stock Option (right to buy) Award $0 +41.3K $0.00 41.3K Aug 16, 2021 Common Stock 41.3K $155.87 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 100 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on July 30, 2021.
F3 These shares represent restricted stock units and will be settled in common stock upon vesting.
F4 Shares shall vest at a rate of 25% on each anniversary of August 15, 2021 until all shares are fully vested at the end of four years.
F5 Options shall vest at a rate of 25% one year from grant date and monthly thereafter until all options are fully vested four years from grant date.